html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 22 Ovulation induction in women with polycystic ovary syndrome Shawky Z. A. Badawy andBotros R. M. B. Rizk Introduction Our knowledge of polycystic ovary syndrome (PCOS)…
Figure 6.1 Human steroidogenic and steroid-inactivating enzymes in peripheral intracrine tissues. 4-dione, androstenedione; A-dione, 5α-androstane-3,17-dione; ADT, androsterone; epi-ADT, epiandrosterone; E1, estrone; E1-S, estrone sulfate; E2, 17β-estradiol; E2-S, estradiol sulfate; 5-diol,…
Figure 2.1 Ludwig’s classification of FPHL. Adapted with permission from Ludwig [30], John Wiley and Sons ©. Evaluation Diagnosis of FPHL is usually made clinically. However, histological evaluation using a…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 21 Polycystic ovary syndrome ovulation induction Carolyn J. Alexander Introduction Polycystic ovary syndrome (PCOS) is one of the most common causes of ovulatory dysfunction and identifiable…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 20 Lifestyle, diet, and exercise in polycystic ovary syndrome Elizabeth Burt andRina Agrawal Introduction Subfertility is a diagnosis that affects 80 million people worldwide [1] and…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 19 Androgens and DHEA in postmenopausal medicine Lila E. Nachtigall andJeffrey A Goldstein Introduction The steady decline of serum androgen levels across the lifespan of an…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 15 Testosterone replacement in the aging male: Lessons learned from the Women’s Health Initiative David Muram andCraig F. Donatucci Introduction Aging in men leads to decline…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 14 Cognitive and behavioral impact of androgen disorders in females: Learning from complete androgen insensitivity syndrome and congenital adrenal hyperplasia Amy B. Wisniewski Introduction Many behaviors…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 13 Androgen-producing ovarian tumors Patricia Carney Introduction As the attending physician covering the resident gynecology clinic, it was not unusual for a student or a resident…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> 9 Polycystic ovary syndrome and cardiovascular risk Heather R. Burks andRobert A. Wild Women diagnosed with polycystic ovary syndrome (PCOS) have a higher prevalence of several…
